Quantum Biopharma (QNTM) Interest Coverage Ratio (2019 - 2026)
Quantum Biopharma (QNTM) reported Interest Coverage Ratio of 129.79 for Q1 2026, up 3.06% on a YoY basis from 125.94 in Q1 2025, and down 497.23% sequentially from 32.67 in Q4 2025.
Quantum Biopharma (QNTM) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Interest Coverage Ratio data on file, last reported at 129.79 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 3.06% year-over-year to 129.79; the trailing twelve-month figure through Mar 2026 stood at 93.68 (up 67.19% YoY), and the FY2025 full-year result was 96.81, up 80.19% from the prior year.
- Interest Coverage Ratio eased to 129.79 in Q1 2026, from 32.67 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 288.03 in Q1 2022 to a low of 4148.75 in Q1 2023.
- A 5-year average of 569.89 and a median of 157.87 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio plunged 1540.4% in 2023 and surged 102.93% in 2025, its largest moves.
- Tracing QNTM's Interest Coverage Ratio over 5 years: stood at 288.03 in 2022, then sank by 287.58% to 540.27 in 2023, then plunged by 106.46% to 1115.43 in 2024, then surged by 102.93% to 32.67 in 2025, then tumbled by 497.23% to 129.79 in 2026.
- Business Quant data shows QNTM's Interest Coverage Ratio at 129.79 in Q1 2026, 32.67 in Q4 2025, and 51.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | -129.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.79 |
| Dec 31, 2025 | 32.67 |
| Sep 30, 2025 | -51.09 |
| Jun 30, 2025 | -41.50 |
| Mar 31, 2025 | -133.89 |
| Dec 31, 2024 | -1,115.43 |
| Sep 30, 2024 | -403.15 |
| Jun 30, 2024 | -413.62 |
| Mar 31, 2024 | -181.84 |
| Sep 30, 2023 | -540.27 |
| Mar 31, 2023 | -4,148.75 |
| Mar 31, 2022 | 288.03 |
| Jun 30, 2021 | -670.79 |
| Mar 31, 2021 | 507.25 |
| Sep 30, 2020 | -215.74 |
| Jun 30, 2020 | -70.52 |
| Mar 31, 2020 | -68.74 |
| Dec 31, 2019 | -137.41 |
| Sep 30, 2019 | -115.99 |